A Phase 3 Study of Siltuximab or Placebo in Combination With Velcade and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01266811
Recruitment Status : Withdrawn (Study canceled based on results of different study with similar hypothesis, investigational agent, & patient)
First Posted : December 24, 2010
Last Update Posted : January 28, 2013
Information provided by (Responsible Party):
Centocor, Inc.

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : April 2014
  Estimated Study Completion Date : December 2014